These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3140409)

  • 1. Relationship between smoking and fibrinolytic system with special reference to t-PA and PA inhibitor.
    Hashimoto Y; Kobayashi A; Yamazaki N; Takada Y; Takada A
    Thromb Res; 1988 Aug; 51(3):303-11. PubMed ID: 3140409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
    Auwerx J; Bouillon R; Collen D; Geboers J
    Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in various parameters of fibrinolysis in persons infused with tissue plasminogen activator: special reference to plasminogen activator inhibitor.
    Takada A; Hou P; Mori T; Takada Y
    Thromb Res Suppl; 1988; 8():23-33. PubMed ID: 3144766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C; Jie AF; Rijken DC; Verheijen JH
    Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
    Takada Y; Takada A
    Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
    Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
    Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
    Haire WD; Goldsmith JC; Rasmussen J
    Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic response during exercise and epinephrine infusion in the same subjects.
    Chandler WL; Veith RC; Fellingham GW; Levy WC; Schwartz RS; Cerqueira MD; Kahn SE; Larson VG; Cain KC; Beard JC
    J Am Coll Cardiol; 1992 Jun; 19(7):1412-20. PubMed ID: 1593033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fibrinolysis in coronary artery disease.
    Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
    Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.
    Kruithof EK; Tran-Thang C; Gudinchet A; Hauert J; Nicoloso G; Genton C; Welti H; Bachmann F
    Blood; 1987 Feb; 69(2):460-6. PubMed ID: 2432970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.
    Kruithof EK; Nicolosa G; Bachmann F
    Blood; 1987 Nov; 70(5):1645-53. PubMed ID: 3117137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.
    Lucore CL; Sobel BE
    Circulation; 1988 Mar; 77(3):660-9. PubMed ID: 2449299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
    Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
    Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.